Search Results - "Gjesdal, C. G."

Refine Results
  1. 1

    Incidence of giant cell arteritis in Western Norway 1972-2012: a retrospective cohort study by Brekke, L K, Diamantopoulos, A P, Fevang, B-T, Aβmus, J, Esperø, E, Gjesdal, C G

    Published in Arthritis research & therapy (15-12-2017)
    “…Giant cell arteritis (GCA) is the most common systemic vasculitis in persons older than 50 years. The highest incidence rates of the disease have been reported…”
    Get full text
    Journal Article
  2. 2

    Survival and death causes of patients with giant cell arteritis in Western Norway 1972-2012: a retrospective cohort study by Brekke, L K, Fevang, B-T S, Diamantopoulos, A P, Assmus, J, Esperø, E, Gjesdal, C G

    Published in Arthritis research & therapy (25-06-2019)
    “…Our objective was to determine the survival and causes of death in a large and well-characterized cohort of patients with giant cell arteritis (GCA). This is a…”
    Get full text
    Journal Article
  3. 3

    Correction to: Incidence of giant cell arteritis in Western Norway 1972-2012: a retrospective cohort study by Brekke, L K, Diamantopoulos, A P, Fevang, B-T, Aβmus, J, Esperø, E, Gjesdal, C G

    Published in Arthritis research & therapy (07-12-2018)
    “…Following publication of the original article [1], the authors reported an error…”
    Get full text
    Journal Article
  4. 4

    Trends in the occurrence of ischaemic heart disease over time in rheumatoid arthritis: 1821 patients from 1972 to 2017 by Alsing, CL, Nystad, TW, Igland, J, Gjesdal, CG, Midtbø, H, Tell, GS, Fevang, BT

    Published in Scandinavian journal of rheumatology (04-05-2023)
    “…To evaluate trends of acute myocardial infarction (AMI) and ischaemic heart disease (IHD) in rheumatoid arthritis (RA) patients compared with the general…”
    Get full text
    Journal Article
  5. 5

    Vitamin K2 supplementation does not influence bone loss in early menopausal women: a randomised double-blind placebo-controlled trial by Emaus, N, Gjesdal, C. G, Almås, B, Christensen, M, Grimsgaard, A. S, Berntsen, G. K. R, Salomonsen, L, Fønnebø, V

    Published in Osteoporosis international (01-10-2010)
    “…Summary Vitamin K2 may preserve bone strength and reduce fracture risk. In this randomised double-blind placebo-controlled trial among healthy postmenopausal…”
    Get full text
    Journal Article
  6. 6

    Interferon gamma (IFN-γ)-mediated inflammation and the kynurenine pathway in relation to risk of hip fractures: the Hordaland Health Study by Apalset, E. M., Gjesdal, C. G., Ueland, P. M., Øyen, J., Meyer, K., Midttun, Ø., Eide, G. E., Tell, G. S.

    Published in Osteoporosis international (01-08-2014)
    “…Summary The cytokine interferon gamma (IFN-γ) stimulates neopterin release and tryptophan degradation into kynurenines through the kynurenine pathway. High…”
    Get full text
    Journal Article
  7. 7

    Low-energy distal radius fractures in middle-aged and elderly men and women—the burden of osteoporosis and fracture risk by Øyen, J, Gjesdal, C. G, Brudvik, C, Hove, L. M, Apalset, E. M, Gulseth, H. C, Haugeberg, G

    Published in Osteoporosis international (01-07-2010)
    “…Summary One third of 218 men and half of 1,576 women with low-energy distal radius fractures met the bone mineral density (BMD) criteria for osteoporosis…”
    Get full text
    Journal Article
  8. 8

    Low-energy distal radius fractures in middle-aged and elderly men and women—the burden of osteoporosis and fracture risk: A study of 1794 consecutive patients by Øyen, J., Gjesdal, C. G., Brudvik, C., Hove, L. M., Apalset, E. M., Gulseth, H. C., Haugeberg, G.

    Published in Osteoporosis international (01-07-2010)
    “…Summary One third of 218 men and half of 1,576 women with low-energy distal radius fractures met the bone mineral density (BMD) criteria for osteoporosis…”
    Get full text
    Journal Article
  9. 9

    Weight loss and distal forearm fractures in postmenopausal women: The Nord-Trøndelag health study, Norway by Omsland, T. K., Schei, B., Grønskag, A. B., Langhammer, A., Forsén, L., Gjesdal, C. G., Meyer, H. E.

    Published in Osteoporosis international (01-12-2009)
    “…Summary Weight loss is a risk factor for hip fractures, but few studies have evaluated the effect of weight loss on distal forearm fracture risk. In this…”
    Get full text
    Journal Article
  10. 10

    Regional differences in hip bone mineral density levels in Norway: the NOREPOS study by Omsland, T. K, Gjesdal, C. G, Emaus, N, Tell, G. S, Meyer, H. E

    Published in Osteoporosis international (01-04-2009)
    “…Summary Large regional differences in hip fracture rates within Norway have previously been shown. However, regional differences in hip bone mineral density…”
    Get full text
    Journal Article
  11. 11

    Continued decline in hip fracture incidence in Norway: a NOREPOS study by Søgaard, A. J., Holvik, K., Meyer, H. E., Tell, G. S., Gjesdal, C. G., Emaus, N., Grimnes, G., Schei, B., Forsmo, S., Omsland, T. K.

    Published in Osteoporosis international (01-07-2016)
    “…Summary The previously reported decline in age-adjusted hip fracture rates in Norway during 1999–2008 continued after 2008. The annual number of hip fractures…”
    Get full text
    Journal Article
  12. 12

    Identifying low muscle mass in patients with hip fracture: Validation of bioelectrical impedance analysis and anthropometry compared to dual energy X-ray absorptiometry by Steihaug, Ole Martin, Gjesdal, C. G., Bogen, B., Ranhoff, A. H.

    Published in The Journal of nutrition, health & aging (01-07-2016)
    “…Background Older hip fracture patients often have reduced muscle mass, which is associated with adverse outcomes. Dual energy X-ray absorptiometry (DXA) can…”
    Get full text
    Journal Article
  13. 13

    Interferon (IFN)‐γ‐mediated inflammation and the kynurenine pathway in relation to bone mineral density: the Hordaland Health Study by Apalset, E. M., Gjesdal, C. G., Ueland, P. M., Midttun, Ø., Ulvik, A., Eide, G. E., Meyer, K., Tell, G. S.

    Published in Clinical and experimental immunology (01-06-2014)
    “…Summary The risk of osteoporosis increases in inflammatory disorders. In cell‐mediated immune activation, interferon (IFN)‐γ stimulates macrophage release of…”
    Get full text
    Journal Article
  14. 14

    Assays for Infliximab Drug Levels and Antibodies: A Matter of Scales and Categories by Bader, L. I., Solberg, S. M., Kaada, S. H., Bolstad, N., Warren, D. J., Gavasso, S., Gjesdal, C. G., Vedeler, C. A.

    Published in Scandinavian journal of immunology (01-09-2017)
    “…Immunogenicity is a frequent cause of secondary non‐response to tumour necrosis factor (TNF) inhibitors. Drug level measurement and detection of antidrug…”
    Get full text
    Journal Article
  15. 15

    Low serum concentrations of alpha-tocopherol are associated with increased risk of hip fracture. A NOREPOS study by Holvik, K., Gjesdal, C. G., Tell, G. S., Grimnes, G., Schei, B., Apalset, E. M., Samuelsen, S. O., Blomhoff, R., Michaëlsson, K., Meyer, H. E.

    Published in Osteoporosis international (01-11-2014)
    “…Summary We investigated the risk of hip fracture according to circulating alpha-tocopherol, a plant-derived substance with antioxidant properties, in…”
    Get full text
    Journal Article
  16. 16

    Plasma dimethylglycine, nicotine exposure and risk of low bone mineral density and hip fracture: the Hordaland Health Study by Øyen, J., Svingen, G. F. T., Gjesdal, C. G., Tell, G. S., Ueland, P. M., Lysne, V., Apalset, E. M., Meyer, K., Vollset, S. E., Nygård, O. K.

    Published in Osteoporosis international (01-05-2015)
    “…Summary In the large community-based Hordaland Health Study, low plasma dimethylglycine was associated with low bone mineral density in both middle-aged and…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Plasma total homocysteine level and bone mineral density: the Hordaland Homocysteine Study by Gjesdal, Clara Gram, Vollset, Stein Emil, Ueland, Per Magne, Refsum, Helga, Drevon, Christian A, Gjessing, Håkon K, Tell, Grethe S

    Published in Archives of internal medicine (1960) (09-01-2006)
    “…Plasma total homocysteine (tHcy) has been associated with hip fracture but not directly with bone mineral density (BMD). We examined the association of hip BMD…”
    Get more information
    Journal Article
  19. 19

    Assays for Infliximab Drug Levels and Antibodies: Aᅡ Matter of Scales and Categories by Bader, L I, Solberg, S M, Kaada, S H, Bolstad, N, Warren, D J, Gavasso, S, Gjesdal, C G, Vedeler, C A

    Published in Scandinavian journal of immunology (01-09-2017)
    “…Immunogenicity is a frequent cause of secondary non-response to tumour necrosis factor (TNF) inhibitors. Drug level measurement and detection of antidrug…”
    Get full text
    Journal Article
  20. 20

    Interferon (IFN)-[gamma]-mediated inflammation and the kynurenine pathway in relation to bone mineral density: the Hordaland Health Study by Apalset, E M, Gjesdal, C G, Ueland, P M, Midttun, Ø, Ulvik, A, Eide, G E, Meyer, K, Tell, G S

    Published in Clinical and experimental immunology (01-06-2014)
    “…Summary The risk of osteoporosis increases in inflammatory disorders. In cell-mediated immune activation, interferon (IFN)-[gamma] stimulates macrophage…”
    Get full text
    Journal Article